Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)

    This upcoming NIH grant will fund innovative research developing advanced bioinformatics and computational biology tools to improve biomedical data analysis and health outcomes, encouraging interdisciplinary and technology-driven projects.

    Browse similar grants
    AI in Healthcare Research GrantsCancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Research Grants in Clinical Informatics (R01 Clinical Trial Optional)

    The National Library of Medicine will soon fund innovative, scalable clinical informatics research to develop and evaluate tools that transform diverse health data into actionable knowledge for improved health care and outcomes.

    HHS-NIH11Due Mar 5, 2029$250,000

    Forecast to Publish a Funding Opportunity Announcement for Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

    The National Cancer Institute will soon invite applications to develop innovative, user-friendly informatics technologies that advance cancer research, spanning early tool development to initial dissemination.

    HHS-NIH11Due Oct 19, 2027$300,000

    Bioengineering Research Grants (R01 Clinical Trial Optional)

    This grant supports small multidisciplinary teams using bioengineering approaches to develop and advance innovative tools or methods for solving biomedical research or clinical problems.

    HHS-NIH11Due Jul 5, 2029$500,000

    Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

    This grant funds early-stage, highly innovative technology development for improving analysis and handling of biospecimens in basic or clinical cancer research, focusing on proof-of-concept studies.

    HHS-NIH11Due Nov 10, 2026· 15d$150,000

    Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

    This grant funds projects to further develop and validate innovative technologies that advance cancer research or clinical care, focusing on technical improvements and rigorous validation for broad adoption.

    HHS-NIH11Forecasted Jun 4, 2027$300,000Forecasted